无信息游离DNA检测的阳性预测值及结局:意大利多中心细胞遗传学与细胞基因组学诊断检测审计(ICARO研究)
该研究基于意大利全国独立临床细胞遗传学实验室2013年至2020年3月的产前诊断数据,分析了无创产前检测(NIPT)阳性、无结果及胎儿性别不一致病例的阳性预测值(PPV)。结果显示T21和XYY的PPV最高,罕见常染色体三体和复发性微缺失最低;绒毛膜绒毛取样确诊的PPV显著高于羊水。无结果病例中13.9%检出细胞遗传学异常,性别不一致病例中部分通过后续基因检测获得解释。
要点
- T21的PPV为93%(624/671),XYY为96.3%(26/27),罕见常染色体三体为19.1%(9/47),复发性微缺失为14.5%(8/55)。
- 绒毛膜绒毛取样确诊的T21、T18、T13的PPV(97.5%)显著高于羊水(89.5%)(p < 0.001)。
- 无结果病例中13.9%(19/139)检出细胞遗传学异常;6例NIPT与超声性别不一致中3例通过后续基因检测获得解释。
核心结论
- NIPT的PPV因筛查条件和诊断检测所用组织不同而异;性别不一致和无结果问题凸显了检测前后咨询的重要性。
研究设计与样本
- 基于意大利全国独立临床细胞遗传学实验室的调查数据,纳入2013年至2020年3月间的产前诊断检测结果,包括NIPT阳性、NIPT无结果及NIPT与超声性别不一致的病例。
主要发现
- 共收集1327例NIPT阳性女性的诊断检测结果。
- T21的PPV为93%(624/671),XYY的PPV为96.3%(26/27),罕见常染色体三体的PPV为19.1%(9/47),复发性微缺失的PPV为14.5%(8/55)。
- T21、T18、T13在绒毛膜绒毛取样确诊时的PPV为97.5%,显著高于羊水确诊的89.5%(p < 0.001)。
- 在139例无结果病例中,19例(13.9%)检出细胞遗传学异常。
- 6例NIPT与超声性别不一致的病例中,3例通过后续基因检测获得解释。
关键数值与推荐
- T21的PPV为93%(624/671),XYY的PPV为96.3%(26/27)。
- 罕见常染色体三体的PPV为19.1%(9/47),复发性微缺失的PPV为14.5%(8/55)。
- T21、T18、T13在绒毛膜绒毛取样确诊时的PPV为97.5%,在羊水确诊时为89.5%(p < 0.001)。
- 无结果病例中细胞遗传学异常检出率为13.9%(19/139)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To establish the positive predictive values (PPV) of cfDNA testing based on data from a nationwide survey of independent clinical cytogenetics laboratories. METHODS: Prenatal diagnostic test results obtained by Italian laboratories between 2013 and March 2020 were compiled for women with positive non-invasive prenatal tests (NIPT), without an NIPT result, and cases where there was sex discordancy between the NIPT and ultrasound. PPV and other summary data were reviewed. RESULTS: Diagnostic test results were collected for 1327 women with a positive NIPT. The highest PPVs were for Trisomy (T) 21 (624/671, 93%) and XYY (26/27, 96.3%), while rare autosomal trisomies (9/47, 19.1%) and recurrent microdeletions (8/55, 14.5%) had the lowest PPVs. PPVs for T21, T18, and T13 were significantly higher when diagnostic confirmation was carried out on chorionic villi (97.5%) compared to amniotic fluid (89.5%) (p < 0.001). In 19/139 (13.9%), of no result cases, a cytogenetic abnormality was detected. Follow-up genetic testing provided explanations for 3/6 cases with a fetal sex discordancy between NIPT and ultrasound. CONCLUSIONS: NIPT PPVs differ across the conditions screened and the tissues studied in diagnostic testing. This variability, issues associated with fetal sex discordancy, and no results, illustrate the importance of pre- and post-test counselling.
引用
- Grati FR, Bestetti I, De Siero D, et al. Positive predictive values and outcomes for uninformative cell-free DNA tests: An Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study). Prenat Diagn. 2022. PMID: 36403097. doi:10.1002/pd.6271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。